8.3 |
25.0 |
GO:2000854 |
positive regulation of corticosterone secretion(GO:2000854) |
8.2 |
24.5 |
GO:1904395 |
retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
7.7 |
15.5 |
GO:1901628 |
positive regulation of postsynaptic membrane organization(GO:1901628) |
6.7 |
120.0 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
6.2 |
43.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
6.1 |
18.3 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
5.6 |
16.8 |
GO:2000864 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
5.0 |
14.9 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
4.7 |
23.6 |
GO:0030070 |
insulin processing(GO:0030070) |
4.2 |
20.8 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
4.1 |
12.4 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
4.1 |
16.3 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
3.9 |
61.9 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.7 |
14.6 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
3.6 |
10.8 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
3.6 |
14.2 |
GO:0007525 |
somatic muscle development(GO:0007525) |
3.5 |
35.1 |
GO:0051612 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.4 |
13.6 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
3.2 |
35.6 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
3.2 |
9.7 |
GO:0072019 |
carbon dioxide transmembrane transport(GO:0035378) proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
3.0 |
15.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
3.0 |
11.9 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
2.5 |
22.7 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
2.5 |
22.6 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
2.4 |
7.2 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
2.4 |
7.2 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
2.3 |
70.9 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
2.2 |
6.5 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
2.1 |
29.8 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
2.0 |
10.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.8 |
7.2 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
1.8 |
5.3 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
1.7 |
23.7 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
1.7 |
5.0 |
GO:2000705 |
histone H3-T6 phosphorylation(GO:0035408) dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
1.6 |
8.1 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
1.6 |
6.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
1.5 |
10.8 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
1.5 |
6.1 |
GO:1902748 |
positive regulation of lens fiber cell differentiation(GO:1902748) |
1.5 |
6.1 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
1.5 |
14.6 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
1.4 |
56.2 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.4 |
4.3 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
1.4 |
12.8 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
1.4 |
19.3 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
1.3 |
8.1 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
1.3 |
5.4 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
1.3 |
12.9 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
1.2 |
3.7 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
1.2 |
7.4 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
1.2 |
3.5 |
GO:0021571 |
rhombomere 5 development(GO:0021571) |
1.1 |
5.7 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
1.1 |
4.5 |
GO:0002503 |
peptide antigen assembly with MHC class II protein complex(GO:0002503) |
1.1 |
4.5 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.1 |
10.9 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
1.0 |
3.1 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.0 |
3.0 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
1.0 |
7.0 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) midbrain-hindbrain boundary development(GO:0030917) |
1.0 |
3.0 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
1.0 |
15.8 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
1.0 |
11.7 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
1.0 |
1.9 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.9 |
7.4 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
0.9 |
5.5 |
GO:1903960 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
0.9 |
19.1 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 |
4.5 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.9 |
24.8 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.9 |
5.3 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
0.8 |
15.0 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
0.8 |
20.0 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
0.7 |
3.0 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
0.7 |
2.9 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
0.7 |
8.4 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.7 |
10.9 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
0.7 |
2.0 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
0.7 |
20.2 |
GO:0009083 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.6 |
5.2 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
0.6 |
1.9 |
GO:0045212 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.6 |
8.7 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
0.6 |
4.3 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
0.6 |
4.9 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.6 |
1.8 |
GO:0032900 |
regulation of nucleoside transport(GO:0032242) negative regulation of neurotrophin production(GO:0032900) |
0.6 |
2.4 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
0.6 |
12.4 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
0.6 |
2.8 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
0.6 |
7.9 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
0.5 |
4.9 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
0.5 |
4.6 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
0.5 |
12.3 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.5 |
5.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 |
4.7 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
0.5 |
1.4 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.5 |
0.9 |
GO:0045636 |
positive regulation of melanocyte differentiation(GO:0045636) |
0.5 |
1.4 |
GO:2000566 |
positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.4 |
2.1 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 |
13.8 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
0.4 |
1.2 |
GO:0036060 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.4 |
6.4 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
0.4 |
9.0 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
0.4 |
4.1 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
0.4 |
3.0 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.4 |
7.7 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
0.4 |
3.3 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.3 |
3.8 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 |
2.3 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 |
1.6 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 |
5.0 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 |
1.2 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
0.3 |
1.1 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 |
11.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 |
2.4 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
0.3 |
4.9 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 |
0.8 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.3 |
0.8 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.2 |
2.7 |
GO:0033227 |
dsRNA transport(GO:0033227) |
0.2 |
3.7 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
0.2 |
4.6 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
0.2 |
3.6 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.2 |
4.0 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
0.2 |
1.6 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
0.2 |
1.6 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
0.2 |
1.6 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
0.2 |
1.4 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
0.2 |
1.6 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
0.2 |
5.0 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 |
7.7 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
0.2 |
0.9 |
GO:0034343 |
microglial cell activation involved in immune response(GO:0002282) type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 |
2.4 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
0.2 |
2.0 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.2 |
8.3 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
0.2 |
3.9 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
0.2 |
5.8 |
GO:0015813 |
acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
0.2 |
2.9 |
GO:0002467 |
germinal center formation(GO:0002467) |
0.2 |
9.6 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
0.2 |
2.6 |
GO:0015671 |
oxygen transport(GO:0015671) |
0.2 |
5.8 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
0.2 |
0.8 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.2 |
56.6 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 |
7.1 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
0.2 |
1.2 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 |
12.4 |
GO:0009060 |
aerobic respiration(GO:0009060) |
0.2 |
2.8 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
0.2 |
6.0 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
0.2 |
12.2 |
GO:0070126 |
mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
0.2 |
5.3 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
0.2 |
0.2 |
GO:0014724 |
regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 |
5.8 |
GO:0030261 |
chromosome condensation(GO:0030261) |
0.2 |
9.5 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
0.2 |
0.3 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 |
4.2 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
0.1 |
6.1 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
0.1 |
1.5 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
0.1 |
0.4 |
GO:0046541 |
saliva secretion(GO:0046541) |
0.1 |
5.0 |
GO:0070423 |
nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.1 |
11.6 |
GO:0005977 |
glycogen metabolic process(GO:0005977) |
0.1 |
6.6 |
GO:0032210 |
regulation of telomere maintenance via telomerase(GO:0032210) |
0.1 |
4.7 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
0.1 |
0.8 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
0.1 |
4.4 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
0.1 |
2.0 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
0.1 |
3.3 |
GO:0010761 |
fibroblast migration(GO:0010761) |
0.1 |
10.8 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
0.1 |
2.0 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
0.1 |
4.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
0.1 |
14.1 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 |
1.1 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
0.1 |
6.1 |
GO:0032092 |
positive regulation of protein binding(GO:0032092) |
0.1 |
1.0 |
GO:0015074 |
DNA integration(GO:0015074) |
0.1 |
0.4 |
GO:0038170 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 |
3.1 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
0.1 |
2.5 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
0.1 |
2.4 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
0.1 |
2.3 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
0.1 |
0.6 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
0.1 |
0.7 |
GO:0015865 |
purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.1 |
1.8 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 |
0.5 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
0.1 |
3.7 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
0.1 |
0.2 |
GO:0070417 |
cellular response to cold(GO:0070417) |
0.1 |
1.1 |
GO:0097186 |
amelogenesis(GO:0097186) |
0.1 |
1.1 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 |
0.6 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
0.1 |
3.8 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.1 |
0.7 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 |
0.1 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.0 |
1.9 |
GO:0030317 |
sperm motility(GO:0030317) |
0.0 |
1.3 |
GO:0007586 |
digestion(GO:0007586) |
0.0 |
0.8 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
0.0 |
0.3 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
0.0 |
0.5 |
GO:1903817 |
diaphragm development(GO:0060539) negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 |
0.4 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
0.0 |
1.0 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
0.0 |
1.2 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 |
1.3 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
0.0 |
0.2 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 |
2.0 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
0.0 |
4.6 |
GO:0098656 |
anion transmembrane transport(GO:0098656) |
0.0 |
4.6 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
0.0 |
1.7 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
0.0 |
1.6 |
GO:0007224 |
smoothened signaling pathway(GO:0007224) |
0.0 |
2.2 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
0.0 |
0.8 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 |
0.2 |
GO:0050890 |
cognition(GO:0050890) |
0.0 |
3.0 |
GO:0006364 |
rRNA processing(GO:0006364) |
0.0 |
1.1 |
GO:0071805 |
cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |